These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2884190)

  • 1. Effect of mifentidine, a new H2-antagonist, on pentagastrin-stimulated acid secretion in healthy subjects.
    Lazzaroni M; Ardizzone S; Imbimbo BP; Sangaletti O; Ghirardosi C; Bianchi Porro G
    Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):218-21. PubMed ID: 2884190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric acid and pepsin secretion after single oral doses of mifentidine in healthy subjects.
    Lazzaroni M; Imbimbo BP; Sangaletti O; Bianchi Porro G
    Scand J Gastroenterol; 1988 Sep; 23(7):788-92. PubMed ID: 2906453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated pentagastrin-stimulated gastric acid secretory tests carried out in the evaluation of the pharmacodynamics of a new histamine H2-receptor antagonist, SK&F 93479.
    Jönsson KA; Bodemar G; Norlander B; Walan A
    Scand J Gastroenterol; 1984 Mar; 19(2):209-15. PubMed ID: 6144180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ranitidine on gastric acid and pepsin secretion following sham feeding.
    Müller-Lissner SA; Sonnenberg A; Eichenberger P; Blum AL
    Scand J Gastroenterol Suppl; 1981 Jun; 69():27-31. PubMed ID: 6119779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of mifentidine on the secretory response to sham feeding and pentagastrin and on serum gastrin in duodenal ulcer patients.
    Bianchi Porro G; Lazzaroni M; Imbimbo BP; Sangaletti O; Ghirardosi C; Daniotti S
    Eur J Clin Pharmacol; 1987; 32(6):555-8. PubMed ID: 2888658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranitidine inhibits gastric acid and pepsin secretion following sham feeding.
    Müller-Lissner SA; Sonnenberg A; Eichenberger P; Blum AL
    Hepatogastroenterology; 1980 Oct; 27(5):377-80. PubMed ID: 6110626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of mifentidine, a novel H2-receptor antagonist.
    Pagani F; Micheletti R; Brambilla A; Schiavone A; Montagna E; Ciprandi C; Giachetti A
    Arzneimittelforschung; 1985; 35(1A):451-5. PubMed ID: 2859036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of three single doses of oxmetidine administered intravenously on the volume and acidity of gastric secretion, serum prolactin and gastrin concentration in healthy volunteers.
    Wichmann GC; Fölsch UR; von Kleist E; Hasse FM; Dillon M; Clowdus B; Creutzfeldt W
    Z Gastroenterol; 1984 Jun; 22(6):285-93. PubMed ID: 6147051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the new H2-receptor antagonist mifentidine on gastric acid secretion in the cat: comparison with cimetidine and ranitidine.
    Scarpignato C; Tramacere R; Tangwa M; Bertaccini G
    Arch Int Pharmacodyn Ther; 1985 Jul; 276(1):142-51. PubMed ID: 2864903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a histamine H2-receptor antagonist, famotidine, on gastric secretion in healthy subjects.
    Fukuda Y; Ikezoe I; Okabayashi M; Ohama I; Shimoyama T
    Clin Ther; 1987; 9(5):528-35. PubMed ID: 2889528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of gastric acid secretion by intravenous amino acid infusion and its inhibition by H2-receptor antagonists ranitidine and cimetidine.
    Weingart J; Kunert H; Ottenjann R
    Scand J Gastroenterol Suppl; 1981 Jun; 69():61-5. PubMed ID: 6119784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric acid inhibitory profile of ebrotidine, a novel H2-receptor antagonist in humans.
    Maczka M; Kwiecień N; Obtułowicz W; Konturek SJ; Kamiński K; Oleksy J; Gabryelewicz A; Torres J
    J Physiol Pharmacol; 1992 Jun; 43(2):139-48. PubMed ID: 1356519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a conscious rat model for the discovery of novel agents that inhibit gastric acid secretion.
    Campbell CA; Gaskin PJ; Darton J; Chiu P; Lee K; McLean PG
    Eur J Pharmacol; 2008 Jul; 589(1-3):260-3. PubMed ID: 18571645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
    Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Furan H2-antagonist ranitidine inhibits pentagastrin-stimulated gastric secretion stronger than cimetidine.
    Domschke W; Lux G; Domschke S
    Gastroenterology; 1980 Dec; 79(6):1267-71. PubMed ID: 6108279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of esaprazole activity on basal gastric secretion and on pentagastrin-stimulated secretion in healthy volunteers.
    Erembourg L; Reggiani P; Tosi GP; Ferla G; Beinat L
    Int J Clin Pharmacol Res; 1987; 7(2):95-100. PubMed ID: 3583500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the calcium antagonist verapamil on gastric acid secretion in humans.
    Sonnenberg A; Meckel F; Eckhardt U; Scholten T
    Hepatogastroenterology; 1984 Apr; 31(2):80-4. PubMed ID: 6144624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The new histamine H2-receptor antagonist ranitidine. Duration of action.
    Dammann HG; Simon B
    Scand J Gastroenterol Suppl; 1981 Jun; 69():39-43. PubMed ID: 6119781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of pentagastrin-stimulated gastric acid secretion by graded intraduodenal administration of oleic acid in man.
    Kihl B; Olbe L
    Scand J Gastroenterol; 1981; 16(1):121-8. PubMed ID: 7233077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous pentagastrin can induce the illusion of 'tolerance' to a single dose of an H2-blocker in man.
    Nwokolo CU; Sawyerr A; Smith JT; Pounder RE
    Aliment Pharmacol Ther; 1990; 4 Suppl 1():75-83. PubMed ID: 1983349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.